GANX
Gain TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
GANX vs peer average
40/100
GANX vs. peer average (D vs. C)
Grade spread
A 2 · B 1 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
ACRV is the first available peer comparator.
Loose same-sector, similar-market-cap biotech comparator; useful for event-volatility context, not a direct Parkinson’s or indication peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
GANX
Gain Therapeutics
ACRV
Acrivon Therapeutics
Grade
D
F
Momentum
82
88
Value
41
41
Sentiment
54
28
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs ACRV
GANX / ACRV
Grade Position
Below peers
GANX vs. peer average (D vs. C)
40/100
Momentum
82
ACRVValue
41
GANXSentiment
54
GANXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs GANX
ACRV is the first peer returned for this comparison set.